CLEO DIAGNOSTICS LTD - Announcements

3.85%

37.5¢

Market Cap $30.6M

Healthcare Medical Care

Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal... Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. Triage Test is a pre-surgical test to determine ovarian or adnexal mass for which surgical referral is required who have not yet been referred to an oncologist.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

COV	Appendix 4E and 2025 Annual Report	PRICE SENSITIVE	26/08/25	1.22MB	Share
COV	COV Commences Health Economic Study-Support US Market Entry	PRICE SENSITIVE	18/08/25	440.71KB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	21/07/25	740.81KB	Share
COV	CLEO Strengthens FDA Submission - Access to US Biobank	PRICE SENSITIVE	25/06/25	545.31KB	Share
COV	Corporate Presentation	PRICE SENSITIVE	12/06/25	2.56MB	Share
COV	Cleo Advances with Completion of Alpha Testing	PRICE SENSITIVE	12/05/25	526.49KB	Share
COV	CLEO to Fast Track Development of Ovarian Cancer Test	PRICE SENSITIVE	28/04/25	522.41KB	Share
COV	CLEO Receives A$845k Research and Development Tax Incentive	PRICE SENSITIVE	24/04/25	473.54KB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	11/04/25	751.94KB	Share
COV	CLEO Delivers Commercial Development Milestone	PRICE SENSITIVE	18/03/25	511.71KB	Share
COV	Appendix 4D and Half Yearly Accounts	PRICE SENSITIVE	27/02/25	596.53KB	Share
COV	Price Query Response	PRICE SENSITIVE	07/02/25	889.55KB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	31/01/25	812.43KB	Share
COV	CLEO Further Expands Ovarian Cancer Trial with Siles Health	PRICE SENSITIVE	10/12/24	2.71MB	Share
COV	The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial	PRICE SENSITIVE	27/11/24	2.79MB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	16/10/24	711.6KB	Share
COV	Cleo Commences U.S. Clinical Trials	PRICE SENSITIVE	06/09/24	526.04KB	Share
COV	Appendix 4E and 2024 Annual Report	PRICE SENSITIVE	27/08/24	6.18MB	Share
COV	CLEO Selects U.S. Clinical Trial Sites	PRICE SENSITIVE	31/07/24	2.76MB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	24/07/24	732.66KB	Share
COV	Cleo Commences US Regulatory Process with FDA	PRICE SENSITIVE	26/06/24	2.75MB	Share
COV	COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark	PRICE SENSITIVE	29/05/24	2.8MB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	29/04/24	4.39MB	Share
COV	COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials	PRICE SENSITIVE	11/04/24	2.78MB	Share
COV	CLEO Appoints Partner to Commence U.S. Market Access Program	PRICE SENSITIVE	02/04/24	2.79MB	Share
COV	Peer-Review Supports CLEOs Ovarian Cancer Detection Tech	PRICE SENSITIVE	25/03/24	2.79MB	Share
COV	Appendix 4D and Half Yearly Accounts	PRICE SENSITIVE	29/02/24	747.87KB	Share
COV	Cleo Completes Design Transfer	PRICE SENSITIVE	12/02/24	2.7MB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	31/01/24	996.59KB	Share
COV	Completion of First Triage Test Clinical Validation Study	PRICE SENSITIVE	06/11/23	2.96MB	Share
COV	Trading Halt	PRICE SENSITIVE	03/11/23	714.91KB	Share
COV	Pause in Trading	PRICE SENSITIVE	03/11/23	115.61KB	Share
COV	Quarterly activities and cashflow report	PRICE SENSITIVE	30/10/23	4.67MB	Share
COV	Cleo Delivers Early Progress on Development Program	PRICE SENSITIVE	09/10/23	3.17MB	Share
COV	Appendix 4E and Preliminary Financial Report	PRICE SENSITIVE	31/08/23	694.36KB	Share
COV	Suspension from official quotation	PRICE SENSITIVE	11/02/10	30.71KB	Share
COV	Quarterly Report and Appendix 5B	PRICE SENSITIVE	25/01/10	2.51MB	Share
COV +TGF	Corvette Issues Second Convertible Note	PRICE SENSITIVE	18/12/09	67.46KB	Share
COV +TGF	Tianshan and Corvette Agree to AU$60M Merger	PRICE SENSITIVE	17/11/09	98.62KB	Share
COV	Diamond Core Drilling	PRICE SENSITIVE	03/11/09	441.9KB	Share
COV	Activities Report and Appendix 5B	PRICE SENSITIVE	30/10/09	1.99MB	Share
COV	Convertible Note Issued	PRICE SENSITIVE	22/10/09	88.95KB	Share
COV	High Grade Gold Discovery	PRICE SENSITIVE	20/10/09	546.72KB	Share
COV	Two New Gold Zones at Corvette	PRICE SENSITIVE	31/08/09	584.86KB	Share
COV	Quarterly Activities Report	PRICE SENSITIVE	30/07/09	676.18KB	Share
COV	Significant Intersections of High Grade Gold at Stingray	PRICE SENSITIVE	28/07/09	580.45KB	Share
COV	Awarded EIS Drilling Grant Funding	PRICE SENSITIVE	29/06/09	274.67KB	Share
COV	High Grade Gold Intersection from RC Drilling at Corvette	PRICE SENSITIVE	25/06/09	379.95KB	Share
COV	Corvette and CSIRO commence Research Programme	PRICE SENSITIVE	19/05/09	132.38KB	Share
COV	Quarterly Activities and Cashflow Reports	PRICE SENSITIVE	22/04/09	2.75MB	Share
COV	Corvette Intersects 15g/t gold	PRICE SENSITIVE	19/03/09	670.17KB	Share
COV	Half Yearly Accounts	PRICE SENSITIVE	11/03/09	801.88KB	Share
COV	RC Drilling Intersects Gold along 8 km Structure	PRICE SENSITIVE	05/03/09	592.38KB	Share
COV	Aircore Drilling Enhances Gold Zone	PRICE SENSITIVE	11/02/09	1.47MB	Share
COV	Quarterly Activities Report	PRICE SENSITIVE	22/01/09	2.01MB	Share
COV	Drilling Programme Completed	PRICE SENSITIVE	19/12/08	840.75KB	Share

COV Appendix 4E and 2025 Annual Report
26/08/25	PRICE SENSITIVE	1.22MB	Share
COV COV Commences Health Economic Study-Support US Market Entry
18/08/25	PRICE SENSITIVE	440.71KB	Share
COV Quarterly activities and cashflow report
21/07/25	PRICE SENSITIVE	740.81KB	Share
COV CLEO Strengthens FDA Submission - Access to US Biobank
25/06/25	PRICE SENSITIVE	545.31KB	Share
COV Corporate Presentation
12/06/25	PRICE SENSITIVE	2.56MB	Share
COV Cleo Advances with Completion of Alpha Testing
12/05/25	PRICE SENSITIVE	526.49KB	Share
COV CLEO to Fast Track Development of Ovarian Cancer Test
28/04/25	PRICE SENSITIVE	522.41KB	Share
COV CLEO Receives A$845k Research and Development Tax Incentive
24/04/25	PRICE SENSITIVE	473.54KB	Share
COV Quarterly activities and cashflow report
11/04/25	PRICE SENSITIVE	751.94KB	Share
COV CLEO Delivers Commercial Development Milestone
18/03/25	PRICE SENSITIVE	511.71KB	Share
COV Appendix 4D and Half Yearly Accounts
27/02/25	PRICE SENSITIVE	596.53KB	Share
COV Price Query Response
07/02/25	PRICE SENSITIVE	889.55KB	Share
COV Quarterly activities and cashflow report
31/01/25	PRICE SENSITIVE	812.43KB	Share
COV CLEO Further Expands Ovarian Cancer Trial with Siles Health
10/12/24	PRICE SENSITIVE	2.71MB	Share
COV The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial
27/11/24	PRICE SENSITIVE	2.79MB	Share
COV Quarterly activities and cashflow report
16/10/24	PRICE SENSITIVE	711.6KB	Share
COV Cleo Commences U.S. Clinical Trials
06/09/24	PRICE SENSITIVE	526.04KB	Share
COV Appendix 4E and 2024 Annual Report
27/08/24	PRICE SENSITIVE	6.18MB	Share
COV CLEO Selects U.S. Clinical Trial Sites
31/07/24	PRICE SENSITIVE	2.76MB	Share
COV Quarterly activities and cashflow report
24/07/24	PRICE SENSITIVE	732.66KB	Share
COV Cleo Commences US Regulatory Process with FDA
26/06/24	PRICE SENSITIVE	2.75MB	Share
COV COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark
29/05/24	PRICE SENSITIVE	2.8MB	Share
COV Quarterly activities and cashflow report
29/04/24	PRICE SENSITIVE	4.39MB	Share
COV COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials
11/04/24	PRICE SENSITIVE	2.78MB	Share
COV CLEO Appoints Partner to Commence U.S. Market Access Program
02/04/24	PRICE SENSITIVE	2.79MB	Share
COV Peer-Review Supports CLEOs Ovarian Cancer Detection Tech
25/03/24	PRICE SENSITIVE	2.79MB	Share
COV Appendix 4D and Half Yearly Accounts
29/02/24	PRICE SENSITIVE	747.87KB	Share
COV Cleo Completes Design Transfer
12/02/24	PRICE SENSITIVE	2.7MB	Share
COV Quarterly activities and cashflow report
31/01/24	PRICE SENSITIVE	996.59KB	Share
COV Completion of First Triage Test Clinical Validation Study
06/11/23	PRICE SENSITIVE	2.96MB	Share
COV Trading Halt
03/11/23	PRICE SENSITIVE	714.91KB	Share
COV Pause in Trading
03/11/23	PRICE SENSITIVE	115.61KB	Share
COV Quarterly activities and cashflow report
30/10/23	PRICE SENSITIVE	4.67MB	Share
COV Cleo Delivers Early Progress on Development Program
09/10/23	PRICE SENSITIVE	3.17MB	Share
COV Appendix 4E and Preliminary Financial Report
31/08/23	PRICE SENSITIVE	694.36KB	Share
COVSuspension from official quotation
11/02/10	PRICE SENSITIVE	30.71KB	Share
COVQuarterly Report and Appendix 5B
25/01/10	PRICE SENSITIVE	2.51MB	Share
COV +TGFCorvette Issues Second Convertible Note
18/12/09	PRICE SENSITIVE	67.46KB	Share
COV +TGFTianshan and Corvette Agree to AU$60M Merger
17/11/09	PRICE SENSITIVE	98.62KB	Share
COVDiamond Core Drilling
03/11/09	PRICE SENSITIVE	441.9KB	Share
COVActivities Report and Appendix 5B
30/10/09	PRICE SENSITIVE	1.99MB	Share
COVConvertible Note Issued
22/10/09	PRICE SENSITIVE	88.95KB	Share
COVHigh Grade Gold Discovery
20/10/09	PRICE SENSITIVE	546.72KB	Share
COVTwo New Gold Zones at Corvette
31/08/09	PRICE SENSITIVE	584.86KB	Share
COVQuarterly Activities Report
30/07/09	PRICE SENSITIVE	676.18KB	Share
COVSignificant Intersections of High Grade Gold at Stingray
28/07/09	PRICE SENSITIVE	580.45KB	Share
COVAwarded EIS Drilling Grant Funding
29/06/09	PRICE SENSITIVE	274.67KB	Share
COVHigh Grade Gold Intersection from RC Drilling at Corvette
25/06/09	PRICE SENSITIVE	379.95KB	Share
COVCorvette and CSIRO commence Research Programme
19/05/09	PRICE SENSITIVE	132.38KB	Share
COVQuarterly Activities and Cashflow Reports
22/04/09	PRICE SENSITIVE	2.75MB	Share
COVCorvette Intersects 15g/t gold
19/03/09	PRICE SENSITIVE	670.17KB	Share
COVHalf Yearly Accounts
11/03/09	PRICE SENSITIVE	801.88KB	Share
COVRC Drilling Intersects Gold along 8 km Structure
05/03/09	PRICE SENSITIVE	592.38KB	Share
COVAircore Drilling Enhances Gold Zone
11/02/09	PRICE SENSITIVE	1.47MB	Share
COVQuarterly Activities Report
22/01/09	PRICE SENSITIVE	2.01MB	Share
COVDrilling Programme Completed
19/12/08	PRICE SENSITIVE	840.75KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 37.5¢		Change -0.015(3.85%)		Mkt cap ! $30.6M

Open	High	Low	Value	Volume
39.0¢	39.0¢	37.5¢	$57.09K	150.4K

Buyers (Bids)

No.	Vol.	Price($)
3	28671	37.5¢

Sellers (Offers)

Price($)	Vol.	No.
38.0¢	25000	1

View Market Depth

No.	Vol.	Price($)
3	28671	0.375
2	102972	0.370
3	13575	0.350
2	22767	0.345
6	83767	0.340

Price($)	Vol.	No.
0.380	25000	1
0.390	8832	1
0.395	73910	1
0.400	9271	1
0.410	15919	2

Last trade - 16.10pm 12/09/2025 (20 minute delay)

COV (ASX) Chart

CLEO DIAGNOSTICS LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available